Literature DB >> 26947424

Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis.

N C McAvoy1, S Semple2,3, J M J Richards3,4, A J Robson4, D Patel2,5, A G M Jardine6, K Leyland6, A S Cooper2, D E Newby2,3, P C Hayes1.   

Abstract

BACKGROUND: With advancing liver disease and the development of portal hypertension, there are major alterations in somatic and visceral blood flow. Using phase-contrast magnetic resonance angiography, we characterised alterations in blood flow within the hepatic, splanchnic and extra-splanchnic circulations of patients with established liver cirrhosis. AIM: To compare blood flow in splanchnic and extra-splanchnic circulations in patients with varying degrees of cirrhosis and healthy controls.
METHODS: In a single-centre prospective study, 21 healthy volunteers and 19 patients with established liver disease (Child's stage B and C) underwent electrocardiogram-gated phase-contrast-enhanced 3T magnetic resonance angiography of the aorta, hepatic artery, portal vein, superior mesenteric artery, and the renal and common carotid arteries.
RESULTS: In comparison to healthy volunteers, resting blood flow in the descending thoracic aorta was increased by 43% in patients with liver disease (4.31 ± 1.47 vs. 3.31 ± 0.80 L/min, P = 0.011). While portal vein flow was similar (0.83 ± 0.38 vs. 0.77 ± 0.35 L/min, P = 0.649), hepatic artery flow doubled (0.50 ± 0.46 vs. 0.25 ± 0.15 L/min, P = 0.021) and consequently total liver blood flow increased by 30% (1.33 ± 0.84 vs. 1.027 ± 0.5 L/min, P = 0.043). In patients with liver disease, superior mesenteric artery flow was threefold higher (0.65 ± 0.35 vs. 0.22 ± 0.13 L/min, P < 0.001), while total renal blood flow was reduced by 40% (0.37 ± 0.14 vs. 0.62 ± 0.22 L/min, P < 0.001) and total carotid blood flow unchanged (0.62 ± 0.20 vs. 0.65 ± 0.13 L/min, P = 0.315).
CONCLUSIONS: Rather than a generalised systemic hyperdynamic circulation, liver disease is associated with dysregulated splanchnic vasodilatation and portosystemic shunting that, while inducing a high cardiac output, causes compensatory extra-splanchnic vasoconstriction - the 'splanchnic steal' phenomenon. These circulatory disturbances may underlie many of the manifestations of advanced liver disease.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 26947424     DOI: 10.1111/apt.13571

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

Review 1.  Noninvasive imaging assessment of portal hypertension.

Authors:  Paul Kennedy; Octavia Bane; Stefanie J Hectors; Aaron Fischman; Thomas Schiano; Sara Lewis; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2020-09-14

2.  The Eye as a Non-Invasive Window to the Microcirculation in Liver Cirrhosis: A Prospective Pilot Study.

Authors:  Fiona J Gifford; Francesca Moroni; Tariq E Farrah; Kirstie Hetherington; Tom J MacGillivray; Peter C Hayes; Neeraj Dhaun; Jonathan A Fallowfield
Journal:  J Clin Med       Date:  2020-10-17       Impact factor: 4.241

3.  Hemodynamic Changes and Early Recovery of Liver Graft Function after Liver Transplantation.

Authors:  S H Dashti; A Kasraianfard; A Ebrahimi; M Nassiri-Toosi; M S Pakshir; M Rahimi; A Jafarian
Journal:  Int J Organ Transplant Med       Date:  2020

Review 4.  Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy.

Authors:  Bogdan Procopet; Annalisa Berzigotti
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-17

5.  Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography.

Authors:  Natasha McDonald; David M L Lilburn; Neil J Lachlan; Gillian Macnaught; Dilip Patel; Arjun N A Jayaswal; Peter C Hayes; Scott I Semple; Jonathan A Fallowfield
Journal:  Biomed Res Int       Date:  2017-06-15       Impact factor: 3.411

6.  Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.

Authors:  Victoria K Snowdon; Neil J Lachlan; Anna M Hoy; Patrick W F Hadoke; Scott I Semple; Dilip Patel; Will Mungall; Timothy J Kendall; Adrian Thomson; Ross J Lennen; Maurits A Jansen; Carmel M Moran; Antonella Pellicoro; Prakash Ramachandran; Isaac Shaw; Rebecca L Aucott; Thomas Severin; Rajnish Saini; Judy Pak; Denise Yates; Neelesh Dongre; Jeremy S Duffield; David J Webb; John P Iredale; Peter C Hayes; Jonathan A Fallowfield
Journal:  PLoS Med       Date:  2017-02-28       Impact factor: 11.069

7.  The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.

Authors:  Wouter J Heerink; A Millad Solouki; Rozemarijn Vliegenthart; Simeon J S Ruiter; Egbert Sieders; Matthijs Oudkerk; Koert P de Jong
Journal:  Eur Radiol       Date:  2018-03-13       Impact factor: 5.315

8.  Combined ultrasound and nerve stimulator-guided deep nerve block may decrease the rate of local anesthetics systemic toxicity: a randomized clinical trial.

Authors:  Xu-Hao Zhang; Yu-Jie Li; Wen-Quan He; Chun-Yong Yang; Jian-Teng Gu; Kai-Zhi Lu; Bin Yi
Journal:  BMC Anesthesiol       Date:  2019-06-12       Impact factor: 2.217

9.  Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats.

Authors:  Szu-Yu Liu; Chia-Chang Huang; Shiang-Fen Huang; Tsai-Ling Liao; Nai-Rong Kuo; Ying-Ying Yang; Tzu-Hao Li; Chih-Wei Liu; Ming-Chih Hou; Han-Chieh Lin
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

Review 10.  High-output Cardiac Failure: A Forgotten Phenotype in Clinical Practice.

Authors:  Diane Xavier de Ávila; Humberto Villacorta; Wolney de Andrade Martins; Evandro Tinoco Mesquita
Journal:  Curr Cardiol Rev       Date:  2022
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.